18 Fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab

Ramon F. Barajas, Prakash Ambady, Jeanne Link, Kenneth A. Krohn, Ahmed Raslan, Nadine Mallak, Randy Woltjer, Leslie Muldoon, Edward A. Neuwelt

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of '18 Fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences